Cargando…
Phage therapy for Clostridioides difficile infection
Clostridioides difficile is endemic in the intestinal tract of healthy people. However, it is responsible for many healthcare-associated infections, such as nosocomial diarrhea following antibiotic treatment. Importantly, there have been cases of unsuccessful treatment and relapse related to the eme...
Autores principales: | Fujimoto, Kosuke, Uematsu, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650352/ https://www.ncbi.nlm.nih.gov/pubmed/36389774 http://dx.doi.org/10.3389/fimmu.2022.1057892 |
Ejemplares similares
-
The long and sinuous road to phage-based therapy of Clostridioides difficile infections
por: Umansky, Andrew A., et al.
Publicado: (2023) -
Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
por: Venhorst, Jennifer, et al.
Publicado: (2022) -
Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023) -
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)